Abstract
Objective: The aim is to describe the role and function of polymer or peptide mediated drug delivery system considerations in Nano-formulations.
Background: The Polymers are the basic frameworks of any formulation, more importantly in case of Sustained/controlled release or Nano-particulate forms. The most commonly used polymers composed of PLA (Poly Lactic Acids).
Methods: A systematic search of the published literature was performed by using MEDLINE, EMBASE, the Cochrane Library and Patent Databases.
Results: More than 20 patents and 60 research and review papers were selected and studied in which PLA’s had been used as a formulating agent. The data from literature was transformed in tabular forms for better comparison and understanding of role and function of polymer or peptide mediated drug delivery system considerations.
Conclusion: These transformations usually aid to achieve the desired in-vivo biological activity by protecting the molecule’s first pass metabolism and overcoming toxicity. Moreover, these peptide polymer conjugates have numbers of biomedical remedy applications in the various disorders. These poly-peptide conjugates have been approved by the World Health Organization (WHO) and the Food and Drug Administration (FDA) as materials that can be used in medicine/pharmaceutical delivery vehicles.
Keywords: Applications, bio-medical, peptides, poly-(meric)-acids, polymers, therapeutic.
Current Nanomedicine
Title:Nano-Carrier Systems: An Overview of Poly-Art and Peptide Conjugates
Volume: 6 Issue: 1
Author(s): Permender Rathee, Anjoo Kamboj and Shabir Sidhu
Affiliation:
Keywords: Applications, bio-medical, peptides, poly-(meric)-acids, polymers, therapeutic.
Abstract: Objective: The aim is to describe the role and function of polymer or peptide mediated drug delivery system considerations in Nano-formulations.
Background: The Polymers are the basic frameworks of any formulation, more importantly in case of Sustained/controlled release or Nano-particulate forms. The most commonly used polymers composed of PLA (Poly Lactic Acids).
Methods: A systematic search of the published literature was performed by using MEDLINE, EMBASE, the Cochrane Library and Patent Databases.
Results: More than 20 patents and 60 research and review papers were selected and studied in which PLA’s had been used as a formulating agent. The data from literature was transformed in tabular forms for better comparison and understanding of role and function of polymer or peptide mediated drug delivery system considerations.
Conclusion: These transformations usually aid to achieve the desired in-vivo biological activity by protecting the molecule’s first pass metabolism and overcoming toxicity. Moreover, these peptide polymer conjugates have numbers of biomedical remedy applications in the various disorders. These poly-peptide conjugates have been approved by the World Health Organization (WHO) and the Food and Drug Administration (FDA) as materials that can be used in medicine/pharmaceutical delivery vehicles.
Export Options
About this article
Cite this article as:
Rathee Permender, Kamboj Anjoo and Sidhu Shabir, Nano-Carrier Systems: An Overview of Poly-Art and Peptide Conjugates, Current Nanomedicine 2016; 6 (1) . https://dx.doi.org/10.2174/1877912306999160122160351
DOI https://dx.doi.org/10.2174/1877912306999160122160351 |
Print ISSN 2468-1873 |
Publisher Name Bentham Science Publisher |
Online ISSN 2468-1881 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers